Resources

Finding a new pathway to manage insulin production is a large step towards improving outcomes for patients with diabetes.

New results published about usefulness of artificial beta cell technology in type 1 diabetes patients.

Liraglutide use led to less alcohol intake and suppressed dopamine effects in rodents.

Exercise and diet trumps medication in prevention of diabetes in high-risk patients.

One of the most common and beneficial T2DM drugs may contribute to neuropathy and vitamin deficiency.

Breakfast consumption led to a reverse metabolic state in individuals with type 2 diabetes.

Endocrine-disrupting chemicals pose a public health threat.

A 54-year old male presents to your office for an initial visit. His past medical history is significant for hypertension, hypertriglyceridemia and acute pancreatitis. His current lab results show an A1C 9.1%, which is confirmed on a repeat lab. You would like to start him on an antihyperglycemic treatment regimen. Which of the following two-drug combinations is contraindicated for this patient? Follow the link to take the quiz!

Female, 32 years of age, type 1 diabetes, presented with Stage II partial thickness ulcer between 1st and 2nd toe R foot, and several Stage I areas on both feet. She had recently traveled and had bought several pair of new shoes for her trip.

This week, Associate Medical Editor Joy Pape wraps up her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he talks about his 60+ years of experience as a type 1 diabetes patient and how what he has learned over the years influences his view of his diabetes today.